Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka
dc.contributor.author | Sanchayan, K. | |
dc.contributor.author | Fernandopulle, R. | |
dc.contributor.author | Amarasinghe, A. | |
dc.contributor.author | Thiyahiny, S.N. | |
dc.contributor.author | Sri Ranganathan, S. | |
dc.date.accessioned | 2019-02-21T05:25:00Z | |
dc.date.available | 2019-02-21T05:25:00Z | |
dc.date.issued | 2016-09 | |
dc.identifier.citation | The Ceylon Medical Journal, 61(3):p.99-105 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/24386 | |
dc.publisher | The Sri Lanka Medical Association:Colombo | |
dc.subject | Adverse events following immunisation | |
dc.subject | Cohort event monitoring | |
dc.subject | Live attenuated Japanese encephalitis vaccine | |
dc.subject | Vaccine safety | |
dc.title | Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka | |
dc.type | Article |